Loading organizations...
AvB Ventures operates an Automated Venture Building platform, streamlining early-stage funding. It leverages AI, community intelligence, and data-driven KPIs to identify, evaluate, and scale startups. The platform ensures transparent, AI-driven decisions and rigorous KPI tracking. Its structured process covers sourcing, validation, funding, and exit optimization, fostering efficient venture development.
The company’s leadership draws on a distinct entertainment background, having co-produced animated films and collaborated with prominent figures. This experience in complex project creation informed their pivot to establishing an international investment platform. Their core insight was adapting ecosystem-building skills to cultivate and accelerate new businesses.
AvB Ventures supports early-stage startups and founding teams with resources, capital access, and a global network. Its vision is to accelerate innovation through an integrated ecosystem of AI solutions and expert services. It empowers ventures to build robust foundations, achieve global expansion, and navigate successful public offerings, combining strategic capital with operational guidance.
AvB Ventures has 1 tracked investment across 1 company. The latest tracked deal is $7.0M Series A in ApoGen Biotechnologies in December 2016.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 12, 2016 | ApoGen Biotechnologies | $7.0M Series A | — | AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, ELI Lilly And Company, Johnson & Johnson Innovation, Watson Fund, WRF Capital, WuXi AppTec |